The device enables low-pressure, gradual dilation of the maxillary sinus ostia, which is intended to help patients tolerate the procedure in an office setting under local anesthesia.
The Vent-Os system has also received the CE Mark, Health Canada license and Australian Therapeutic Goods Administration Certificate.
More Articles on Supply Chain:
Reducing Supply Chain Costs
First Navio Unicondylar Knee Replacement Performed in France
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
